HomeCompareWTMVX vs JNJ

WTMVX vs JNJ: Dividend Comparison 2026

WTMVX yields 5.96% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 WTMVX wins by $9.6K in total portfolio value
10 years
WTMVX
WTMVX
● Live price
5.96%
Share price
$11.35
Annual div
$0.68
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$29.6K
Annual income
$871.18
Full WTMVX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — WTMVX vs JNJ

📍 WTMVX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodWTMVXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, WTMVX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
WTMVX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

WTMVX
Annual income on $10K today (after 15% tax)
$506.48/yr
After 10yr DRIP, annual income (after tax)
$740.50/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, WTMVX beats the other by $36.89/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of WTMVX + JNJ for your $10,000?

WTMVX: 50%JNJ: 50%
100% JNJ50/50100% WTMVX
Portfolio after 10yr
$24.8K
Annual income
$849.48/yr
Blended yield
3.42%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

WTMVX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

WTMVX buys
0
JNJ buys
0
No recent congressional trades found for WTMVX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricWTMVXJNJ
Forward yield5.96%3.36%
Annual dividend / share$0.68$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$29.6K$20.0K
Annual income after 10y$871.18$827.78
Total dividends collected$7.4K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: WTMVX vs JNJ ($10,000, DRIP)

YearWTMVX PortfolioWTMVX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,296$595.86$10,676$355.77+$620.00WTMVX
2$12,716$629.04$11,407$389.39+$1.3KWTMVX
3$14,267$661.78$12,198$426.53+$2.1KWTMVX
4$15,960$693.97$13,056$467.62+$2.9KWTMVX
5$17,803$725.51$13,987$513.12+$3.8KWTMVX
6$19,805$756.34$14,998$563.56+$4.8KWTMVX
7$21,978$786.37$16,098$619.52+$5.9KWTMVX
8$24,332$815.55$17,295$681.69+$7.0KWTMVX
9$26,879$843.83$18,599$750.82+$8.3KWTMVX
10$29,632$871.18$20,022$827.78+$9.6KWTMVX

WTMVX vs JNJ: Complete Analysis 2026

WTMVXStock

Under normal circumstances, the fund will invest at least 80% of the value of its net assets (including amounts borrowed for investment purposes) in equity securities of companies of any size, including small- and mid-capitalization companies. It will invest at least 40% of its net assets in stocks of foreign companies drawn from at least three different countries (and at least 30% of its net assets in stocks of foreign companies if market conditions are not favorable).

Full WTMVX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this WTMVX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

WTMVX vs SCHDWTMVX vs JEPIWTMVX vs OWTMVX vs KOWTMVX vs MAINWTMVX vs ABBVWTMVX vs MRKWTMVX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.